Arrowhead Pharmaceuticals, Inc. (ARWR)

Nasdaq · Healthcare · Biotechnology
$41.37-5.22%As of 2026-11-22 · USD
Last session low $41.17Last session high $44.80
52-week low $40.4352-week high $95.49
Market cap
$5.85B
Sector
Healthcare
P/E (TTM)
45.4x
Next earnings
2027-02-04 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)21.8In the oversold range (below 30)
MACD (12, 26, 9)-5.22Below its signal line (-4.41); histogram -0.81
Bollinger %B (20, 2)10%Inside the bands (38.44 to 66.93)
SMA 2052.69Price is 21.5% below
SMA 5059.25Price is 30.2% below
SMA 20070.43Price is 41.3% below
ATR (20)7.06% of priceAverage true range per day
52-week position2%In the lower part of the 40.43 to 95.49 range

About Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.

Latest fiscal yearEnded 2026-09-30: revenue of $450.82M and an operating margin of -156.9%.
Next earnings reportExpected on 2027-02-04 (the date is an estimate).

More in Biotechnology